Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
The Million Dollar Question You Didn’t Know You Could Ask Your Pharmacist
There is a simple and potentially cost-saving question patients may not know they can ask their pharmacists. NPR reports that patients “can pay a lower cash price for prescriptions instead of using their insurance and doling out the amount the policy requires.” But, the pharmacist is often banned from offering this information, so patients have […]
Press Releases
Big Pharma's list prices are crushing America's seniors
WASHINGTON, DC — Seniors are filling fewer prescriptions for brand-named drugs, but they’re spending significantly more because list prices keep going up, according to a new government report. In response, David Mitchell, a cancer patient and founder of Patients For Affordable Drugs, issued the following statement: “Today’s report from the HHS Inspector General makes it […]
News and Reports
Delayed: Explaining one of Big Pharma's favorite tricks
In an attempt to encourage and improve transparency, the FDA released a list of more than 50 drug makers accused by generic drug corporations of stalling providing samples that would increase competition and lower prices. Typically, when a company plans to bring a generic drug to market, it must first show that its drug […]
News and Reports
ICYMI: A Push for Affordable Prices for Taxpayer-Funded Drugs
‘Paying Twice’: A Push for Affordble Prices for Taxpayer-Funded Drugs Robert Pear // The New York Times // May 28, 2018 KEY POINT “We have an incredibly powerful, incredibly productive research and development program being run by N.I.H.,” Ameet Sarpatwari, an instructor at Harvard Medical School, said. “Taxpayers put in money that is paying big […]
News and Reports
PBS NewsHour: Will Trump’s drug prices plan make a difference for patients?
President Trump unveiled his plan for lowering prescription drug prices in a speech on Friday, in which he railed against the “very, very rich” middlemen and assured the American people of “tougher negotiation, more competition and much lower prices at the pharmacy counter.” David Mitchell, a cancer patient and the president of Patients For Affordable […]
News and Reports
MLex Market Insight: How Celgene Uses Safety Concerns to Keep Its $7 Billion Cancer Drug on Top
January 12 Leah Nylen Pam Holt, a retired teacher in Grainger, Indiana, was diagnosed with cancer in 2014. At the time, her treatment — with a derivative of the once-banned sedative thalidomide — cost $588 a month. In the past few months, her share of the bill has risen to $640 a month. “I do […]
News and Reports
New York Times: Humira’s Best-Selling Drug Formula: Start at a High Price. Go Higher.
January 6 Danny Hakim Humira is the best-selling prescription drug in the world. You may have seen the commercials. Because of Humira, a woman with rheumatoid arthritis can wash her puppy in the bathtub, another with colitis can stroll happily through a fair packed with food vendors, while a third suffering from psoriasis can go […]
News and Reports
January 1 JC Reindl We are still losing the battle to contain fast-rising drug prices in Michigan and across the country, but increased scrutiny of pricey pharmaceuticals led to some minor victories in 2017 for more affordable health care, according to several of Michigan’s larger insurers. Prices for many popular branded drugs that made big […]